EP3538183B1 - Electronic add-on module for injection appliances - Google Patents
Electronic add-on module for injection appliances Download PDFInfo
- Publication number
- EP3538183B1 EP3538183B1 EP17791921.4A EP17791921A EP3538183B1 EP 3538183 B1 EP3538183 B1 EP 3538183B1 EP 17791921 A EP17791921 A EP 17791921A EP 3538183 B1 EP3538183 B1 EP 3538183B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- injection
- injection device
- module
- force
- add
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3317—Electromagnetic, inductive or dielectric measuring means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/332—Force measuring means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/43—General characteristics of the apparatus making noise when used correctly
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/583—Means for facilitating use, e.g. by people with impaired vision by visual feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2209/00—Ancillary equipment
Definitions
- the present invention relates to the field of medical injection devices for administering liquid substances, in particular medications or medical substances such as insulin and hormone preparations.
- the invention relates to a medical monitoring system with a portable electronic additional module for attaching to an injection device.
- the patent application EP 2781230 describes an injection device, also known as an auto-injector, for automatically pouring out a medical substance by means of a pre-tensioned distribution or injection spring which presses a stopper into a syringe via a piston rod. Movement of the stopper causes the substance to be dispensed or dispensed through a needle at a distal end of the syringe.
- the discharge spring or another energy storage element can also automatically carry out an insertion movement of the syringe relative to a housing of the device in the distal direction.
- the injection device further comprises a needle protection sleeve that can be displaced in a longitudinal direction between a proximal and a distal position.
- the needle protection sleeve is coupled to a needle protection sleeve spring as a separate drive element, which pushes the needle protection sleeve into the distal position after the substance has been dispensed, in which it laterally surrounds or shields the needle.
- a movable stop element as a feedback device for generating an acoustic signal after a certain amount of substance has been released is accelerated towards a stop by the needle protection sleeve spring.
- a second feedback device with a stop element accelerated by the release spring signals the start of substance release.
- the patent application EP 2182456 describes a portable electronic additional module for placing or snapping onto an injection device and for coupling to a proximal end, in particular to a dose setting button, of the injection device.
- a movable contact element in the form of a ball touches a front end surface of the injection device when the additional module is in place and is coupled to a piezoelectric sensor or a pressure sensor.
- Axial vibrations are detected by the sensor, and characteristic operational states or processes are identified by evaluation electronics in the additional module.
- the additional module has a small extension in a longitudinal direction of the injection device, so that the latter is held directly by the user even when the additional module is attached.
- medication or “medical substance” in this context includes any flowable medical formulation that is suitable for controlled administration using a cannula or hollow needle, for example a liquid, a solution, a gel or a fine suspension containing one or more medicinal active ingredients .
- a drug may therefore be a single active ingredient composition or a premixed or co-formulated multi-active ingredient composition from a single container.
- the term includes in particular drugs such as peptides (e.g. insulins, insulin-containing drugs, GLP-1-containing and derived or analogous preparations), proteins and hormones, biologically derived or active active ingredients, active ingredients based on hormones or genes, nutritional formulations, enzymes and other substances both in solid (suspended) or liquid form.
- the term also includes polysaccharides, vaccines, DNA or RNA or oligonucleotides, antibodies or parts of antibodies as well as suitable base, auxiliary and carrier materials.
- the additional module comprises a force sensor for measuring a time-varying axial force component in the direction of the longitudinal axis that is exerted or transmitted by the injection device to the attached additional module during an injection process.
- the additional module comprises a handle or a preferred grip position for gripping and holding the injection device and the attached additional module, or the additional module and the inserted injection device.
- the handle can be a part of a module housing of the additional module that is ergonomically preformed so that it can be grasped by a hand of a user of the injection device, so that all other areas of the additional module and the injection device that are visible in the coupled state appear to a user as significantly less suitable for grasping.
- a user who only grips the injection device using the handle of the attached additional module cannot introduce any forces directly onto the injection device or remove them from the injection device.
- comparable axial forces are transmitted to the injection device at the puncture point and via the additional module, so that the force sensor in the additional module not only detects a vibration behavior of the injection device but also measures a constant or only slowly changing axial force introduction by the user that does not produce any acceleration can.
- the additional module comprises a sleeve-shaped module housing with a device receptacle or opening into which the injection device is inserted before the start of the injection and which at least partially surrounds the injection device in the attached state.
- the handle is also part of the module housing and surrounds the device holder, and the handle also has an extension in the direction of the longitudinal axis of at least half the width of a user's hand, in particular an extension of at least five or at least eight cm.
- the handle is therefore provided radially outside the device holder, which leads to a more compact shape than an extension on the additional module that extends axially or laterally beyond the injection device.
- a clear width of the device holder is, at least in the area of the handle, slightly larger than an outer diameter of the injection device, so that even at maximum handle pressure, the device holder is not pressed onto the injection device and no friction or holding forces are created in the longitudinal direction over the device holder between the injection device and the additional module Bypassing the force sensor.
- the additional module has a releasable holding mechanism which, when attached, restricts or even makes movement of the additional module relative to the injection device in the direction of the longitudinal axis.
- the holding mechanism secures the injection device and additional module against unintentional decoupling, and the force peaks acting on the additional module in the distal direction when the needle cap is removed can be diverted via the additional module.
- the additional module has evaluation electronics, configured to identify processes in, or states of, the injection device during an injection process, based on measurements of the force sensor, in particular based on significant changes in the axial force caused by movements of the user or by an enabled drive mechanism. For example, the detection of an increase in the measured axial force component to a value that does not fall below a minimum holding force during a certain minimum injection time and a subsequent drop in the axial force to zero can be seen by the evaluation electronics as the effort exerted by a user between the piercing process and removal of the injection device with a corresponding movement of a needle protection sleeve including pressurization of an associated one Needle protection sleeve spring can be identified. Furthermore, superimposed movements of components of the injection device, such as turning a sleeve or deflecting a snapper for locking or unlocking, can lead to an identifiable, time-limited increase or decrease in the measured axial force.
- short-term force surges lasting a few milliseconds and resulting from automatic, spring-driven movements of a stop element of the injection device are also registered or detected to signal the start or end of distribution.
- the measured force impulses can, for example, decay quickly Oscillations or vibrations of the injection device relative to the additional module correspond.
- a start of the distribution is identified by a correlated measurement of a rapid increase in the axial force to a holding force value and a clear force surge, while an end of the distribution is identified by measuring a force surge in combination with a constant axial holding force.
- the signaling preferably includes an unbraked acceleration phase of the stop element and a subsequent stop or impact of the stop element to stimulate vibration in the injection device, which can be perceived primarily by the user as an acoustic or tactile click signal and can also be measured by a suitably placed axial force sensor.
- a short-term force impulse signal from the force sensor is filtered and compared in a comparator or a comparison circuit with a first and preferably a second or further threshold value and converted into a multi-valued, in particular two- or three-valued, discrete event pattern in the output signal of the comparator. If an event pattern determined in this way matches a predetermined and stored base pattern that characterizes a specific base event, the original force impulse signal is identified as belonging to the specific base event.
- a basic event for example a stop of a stop element for signaling a start or end of distribution, has a characteristic multi-valued basic pattern in the axial force output signal of the comparator, which is reflected in every event pattern of a one-time registered stop event.
- the additional module has a microphone or acoustic sensor for measuring an acoustic signal during the injection process, in particular vibrations of the injection device transmitted through the air.
- the evaluation electronics identify the event based on measurements from the microphone and measurements from the force sensor. For example, a start of the distribution is identified by a correlated measurement of a rapid increase in the axial force to a holding force value and a clear acoustic signal, while an end of the distribution is determined by measuring a clear acoustic signal in combination with a constant axial holding force.
- a single-axis or multi-axis acceleration sensor or a gyroscope can also be used as alternatives to the microphone.
- the placement of the sensor in the additional module is less critical compared to the force sensor, which relies on a contact surface with the injection device.
- the additional module continuously measures, on the one hand, an axial, in particular constant, minimum force of the user on the injection device, and, on the other hand, carries out a second measurement with a sensor type different from the force sensor, with the two measurements being evaluated together for event identification.
- a state of the injection device or a process of an injection process can therefore be determined by the additional module solely on the basis of the measurements of the axial force sensor, optionally supplemented by measurements from a second sensor.
- it is a complex detection of a discontinued or released Dose is often neither possible nor necessary for a meaningful determination of the status or process.
- An injection process can be classified as having taken place correctly based on the three events of piercing/start of distribution, end of distribution, and device removal. If the order of these events or a period of time in between does not correspond to expectations, the additional module can generate a corresponding message.
- An additional module according to the invention can advantageously be used repeatedly to monitor the use or use of automatic disposable injection devices or auto-injectors.
- the additional module is suitable for retrofitting existing injection devices that are not available for adaptation or modification.
- no sensors are provided in the injection device for acquiring or processing sensor data about the operation of the device, nor is there a communication interface for transmitting this data to a receiver.
- the force sensors in the additional device must be designed and positioned in such a way that they can detect changes in state or primary signals from within the injection device.
- the additional module comprises a communication unit for wireless communication with a mobile device, for example a cell phone or smartphone, and/or an optical, acoustic, or tactile status indicator.
- a displayed state or status of the system can include a device state of the injection device, a module state of the additional module, or a process state of an ongoing or completed injection process.
- the status indicator can be kept simple and limited to a few LEDs, for example in traffic light colors, and/or an acoustic signal generator to generate speech-independent noises or melodies. This is particularly advantageous in conjunction with the advanced graphical display options and voice output options of a smartphone, since the smartphone, which is wirelessly coupled to the additional module, takes over the refined communication with the user that goes beyond a status display.
- the status information can include information about the expiration of a holding time or waiting time, which the user must wait after the delivery has been completed before the injection device can be safely removed from the injection site.
- a simple recording of the time that has elapsed since the end of the discharge was determined and a comparison with a target duration allows the user to see the time to safely remove the injection device. This can be done both by an additional module with a time recording function and by a mobile device coupled to the additional module with real-time event transmission.
- Fig.1 shows an injection system with an injection device 1 and an additional module 2, both in separate ( Fig.1 above) as well as in assembled or coupled ( Fig.1 below) condition.
- the injection device has an elongated device housing 10 which is symmetrical about a longitudinal axis, and a needle protection sleeve 11 which is located between a first position (in Fig.1 shown) and a second position that releases the needle.
- a needle protection cap remover 12 is mounted on a distal end of the injection device when delivered and must be removed or pulled off before the injection together with a needle protection cap that mechanically protects the needle.
- the additional module has an elongated, sleeve-shaped module housing 20 with a cavity as a device holder for the injection device, which is matched to an external shape of the device housing, so that the injection device can be inserted into the additional module for coupling.
- the additional module has a release button of a holding device 24a, an optical status display 23c, 23d for visual feedback to the user, and side openings 20a, which, when coupled, are aligned with windows 10a in the device housing and enable a view of a substance stored in the injection device .
- the additional module can also be significantly shorter than the injection device, i.e. only around two thirds or a good half as long.
- the module housing has a handle 21 on the outside with a slightly concave handle position, which includes a slight elevation 21a or an area with an enlarged diameter as the distal handle limit to make it easier to absorb user force in the distal direction.
- the distal end of the injection device i.e. the needle protection sleeve
- the needle protection sleeve is pressed onto the injection site by the user so that the needle protection sleeve is pushed into the injection device in the proximal direction under tension of the needle protection sleeve spring and at the same time the needle penetrates the injection site.
- the additional module is designed as a sleeve over a large part of the injection device. This means that the injection device cannot be held unintentionally.
- a clear width or an inside diameter of the device holder is, at least in the area of the handle, larger than an outside diameter of the injection device by an amount of a few tenths of a millimeter that exceeds the manufacturing tolerances.
- the additional module has some play radially relative to the injection device so that they can move towards each other without friction and the entire force is transmitted via the force sensor.
- Fig.2 shows an injection device in longitudinal section, in a state before the injection, into which a syringe 13a filled with a substance to be delivered is inserted with a needle 13b.
- a hollow cylindrical needle protection sleeve 11 has a proximal end in contact with a rigid locking sleeve, which in turn rests on a needle protection sleeve spring 14.
- a first stop element or click element 15a is provided for marking an end of injection (Eol).
- a piston rod is connected to the first stop element by means of cams, so that the first stop element can be moved forward by a small stroke at the beginning of the distribution and the needle protection sleeve spring is thereby further tensioned or compressed.
- the first stop element is released and accelerated proximally backwards by the needle protection sleeve spring, where it hits an end cap and produces a clicking noise that is clearly audible to the user and a noticeable impact.
- a second stop element 15b or click element is provided to mark a start of injection (sol). A click pin is initially locked to the piston rod against relative movement.
- a syringe that is slidably mounted in the injection device which in the delivery state is completely enclosed by the device housing including the needle tip, can be moved relative to the device housing by the force of an insertion and/or ejection spring.
- This automated piercing movement is triggered after the needle protection sleeve has been partially or completely inserted into the injection device.
- An impact of the accelerated syringe on a stop element also causes a significant surge of force followed by an approximately constant holding or dispensing force.
- the previous insertion movement of the needle protection sleeve with simultaneous tensioning of the needle protection sleeve spring can take place slowly, in the case of a preloaded needle protection sleeve spring possibly only after a spring preload force has been overcome.
- the movement can result in a continuous increase in the measured axial force, possibly with the application of a minimum unlocking force that is visible in the force curve and superimposed on the spring compression force Injection locking force.
- the piercing movement can also be started by a trigger button that can be activated by the user.
- Fig.3 shows an exploded view of an additional module according to the invention.
- the module housing includes a first housing half 20b and a second housing half 20c, which are snapped onto a module sleeve 20d.
- the module electronics are housed in an electronics holder 23a in the rear part of the additional module, comprising a force sensor 22 or a pressure sensor, a contact switch 23b for detecting a complete insertion of the injection device into the additional module, a connection indicator 23c for signaling a successful connection establishment with a mobile device, a Status display 23d with LEDs and light guides in the form of a transparent distal end cap.
- a microphone 23e As an energy source, a buzzer or loudspeaker 23g for generating noise, and a communication unit 23h with a Bluetooth Low Energy (BLE) chip including an evaluation unit for signal processing and data storage.
- the status display can in particular show the following states: additional module plugged in, additional module ready, injection running, injection completed, hold time expired, remove additional module, BLE status.
- the status display can also issue warnings such as additional module installed incorrectly, additional module switches off due to inactivity, battery level low, reminder to remove additional module, or even error messages such as injection termination during distribution, injection termination during hold time.
- a holding device or a holding mechanism comprises an annular transmission element 24b guided in the module sleeve, a holding structure or nose fixedly arranged on the transmission element, a latching spring which moves the transmission element with the holding structure into a holding position, and a release button as an actuating element 24a for moving the transmission element and for release the holding structure from the holding position.
- the holding structure is snapped into a recess such as a notch or a slot in the housing of the injection device.
- This recess can also be used for other purposes and is ideally already present in existing injection devices, which means that no adjustment has to be made to the injection device to use the additional module.
- the actuating element can also carry out a pushing movement.
- the injection device can slide out of the additional module in the axial direction, so the holding mechanism allows the additional module to be releasably snapped onto the injection device.
- the module housing in Fig.3 differs from the one in Fig.1 , in particular due to the arrangement of the holding device within the handle area instead of between the handle area and the distal end of the housing. The holding device is therefore held by the user when holding it; in this case, the release button is slightly recessed in the module housing in order to prevent unintentional release by the user's holding hand.
- the holding device can have some play in the axial direction, so that the force sensor can move away from the end cap or contact surface.
- the force sensor can also be preloaded or prestressed by force-fitting snapping of the holding structure of the additional module into the recess of the injection device.
- a prestressing section in the module housing between the holding device and the force sensor is correspondingly preloaded in tension, and under certain circumstances external axial forces can only be observed on the force sensor above a certain prestressing value.
- a force sensor placed on the proximal end face of the injection device initially measures the preload value as well as any small user force, which is diverted backwards, for example, bypassing the preload path.
- part of the user's axial force is at least partially directed to the force sensor via the preload path. This first reduces the tensile load in the pre-tensioning section, and only user forces above a minimum value that does not exceed the pre-tensioning force are measured by the force sensor in addition to the pre-tensioning force.
- the axial force sensor comes to rest at the proximal, or rear, end of the injection device when the additional module is in place. It therefore touches a proximal end face or end cap of the injection device, which represents a simplification compared to force transmission via a contact surface to be provided on the side of the device perpendicular to the axis, for example via a proximal annular surface of a circumferential flange or a section thereof. It is also conceivable to redirect the axial force by means of movable components on the additional module in a direction that deviates from the longitudinal direction, for example for non-axial placement of the force sensor.
- Suitable force sensors are based on a piezoresistive effect, i.e. on a change in the specific electrical resistance of a conductor when mechanically deformed.
- force sensors from the FSS series from Honeywell, the resistance of piezoresistors integrated into a silicon measuring element increases when they are bent by force, which can be measured via a resistance bridge.
- the sensor transmits an applied force between zero and 20 Newtons directly to the silicon measuring element via a stainless steel ball, moving the ball by a maximum stroke of 50 micrometers.
- Alternative force sensors for measuring holding forces include strain gauges mounted on bending beams, or FSR (Force Sensing Resistor) pressure sensors.
- the evaluation unit can be integrated in the communication unit 23h or provided as an independent chip on the electronics holder.
- the evaluation unit processes the signals from the force sensor and any other sensors provided, provides a time stamp, and determines consolidated injection information from the processed signals and the associated time stamps.
- the latter includes at least the information that an injection was carried out successfully at a certain point in time, or what incorrect actions may have been taken.
- This information is in a Storage unit stored in the additional module and/or forwarded via the communication unit.
- the storage unit can also store identification data of the user or the additional module.
- the contact switch 23b can also function as an activation element to activate the additional module from a power saving mode.
- the energy source can be rechargeable, for which the additional module has a suitable plug or is intended for inductive energy transmission from a charging station.
- the charging station can only accommodate the additional module, or the additional module with the injection device inserted, and can also be used by the user's other rechargeable devices.
- An intelligent charging station can function as a base station and have additional functionalities, for example temperature measurement of the inserted injection device or the medication it contains. If the injection device is placed in the charger after storage in the refrigerator and before use, such a temperature measurement on the injection device can output a signal as soon as a minimum temperature for administering the medication is reached.
- the power source of the additional module can also be recharged without further intervention from the user.
- the intelligent charging station can also provide time and date information for synchronizing a clock of the additional module, or accept the consolidated injection information as a fallback level to the mobile device as described below.
- Fig.4 shows the signals from a piezoresistive force sensor (top) and an electret microphone (bottom) measured during a complete injection process lasting 20 seconds.
- the following events are assigned to the signals: (a) connecting the additional module and the injection device, (b) removing the needle protection cap from the injection device, (c) moving/tilting the injection device to the injection site, (d) starting the delivery (Start of Injection, Sol), ( e) End of Injection (Eol), (f) removing the injection device from the injection site, (g) placing the injection device in a horizontal position, (h) putting down the injection device, (i) picking up and dropping the injection device, (j ) Remove injection device from additional module.
- States, processes and events in the injection device and during the injection process can be identified by combinatorially linking the information from the force sensor and the microphone, as follows.
- To detect a start click the combination of a clear acoustic peak and an increase in force (with remaining on the force plateau) is required.
- To detect a final click the combination of a clear acoustic peak and a consistently high force is required.
- the removal of the injection device and additional module from the injection site is detected by the drop in force after the final click. If the injection device is removed from the injection site before the final click or during the required holding time, this can be detected by the premature drop in force.
- Fig.5 shows a diagram for an evaluation electronics as part of the evaluation unit, applicable to an input signal A measured by the force sensor.
- a high-pass filter with a cutoff frequency of 200 Hz ( Fig.5 , left)
- the filtered signal includes both positive and negative deflections, corresponding to the deviations in the force impulse signal compared to a holding force plateau.
- the output signal of the filter is increased to an offset of 2V (half the supply voltage).
- the resulting signal B is passed to a comparator ( Fig.5 , right), which compares the analog signal with an upper and a lower limit of an amplitude window and converts it into pulses.
- a first comparator output value C for example a pulse of plus 1 V
- a second comparator output value D for example a pulse of minus 1 V
- the evaluation electronics can be implemented analog or digital or mixed.
- the high-pass filtered analog sensor signal is fed to a microprocessor, converted by it into a digital signal and fed to the digital comparator function programmed in the microprocessor's memory.
- a sampling rate for the digitization of the force impulse signal must be selected according to Nyquist, so for a force impulse signal corresponding to an acoustic clicking noise with a frequency spectrum of up to 5 kHz, sampling every 20 microseconds is appropriate.
- Fig.6 shows an input signal A measured by a force sensor at the input of a filter, as well as the filtered signal B generated by filtering the signal A at the input of a comparator.
- the entire process shown lasts 5 seconds, so the power surge signals at the beginning and at the end of the distribution corresponding to a start-of-injection and an end-of-injection click are only visible as narrow peaks.
- Fig.7 shows an example of an event pattern formation for the force impulse signal at the beginning of the distribution in Fig.6 , time-resolved over a duration of 8 milliseconds.
- the unfiltered signal A and the filtered signal B show correspondingly more structure.
- a first comparator output signal C is generated with three pulses of different lengths.
- a second comparator output signal D is generated, here comprising a sequence of four pulses of different lengths.
- the sequence of the second pulses is shown here with negative values for better readability.
- the event pattern resulting from the selected force impulse with the two components C and D agrees with the characteristic basic pattern or the signature of a start click, represented by curve E, in that the three pulses of the basic pattern lie completely within pulses of the event pattern in time. Accordingly, the force surge signal is identified as originating from a start click.
- the associated basic pattern E is preferably carried out using an iterative procedure with repeated recording and analysis of force impulses with a known origin. The selected limit values then ideally lead to minimal scatter in the event patterns and thus to high reproducibility.
- the algorithm presented can successfully identify or exclude previous actions and incorrect manipulations such as picking up the additional module, mounting the additional module, removing the needle guard, turning, dropping, loud ambient noises, and shaking holding as force surges that are not relevant to the injection and do not correspond to any basic signal.
- Fig.8 shows an extended medical monitoring system with an injection device 1, an additional module 2, a mobile display and output device 31 which can communicate wirelessly with the additional module, and an optional stationary data processing system or expert system 32 based on de-localized data storage (cloud computing).
- the additional module wirelessly transmits data from an injection process and/or consolidated injection information to a compatible mobile device, for example a smart mobile phone (smartphone) with a special application, or a correspondingly configured portable computer.
- the mobile device must be initially set up and configured, for example by installing an application and registering the user. This can be done using a patient data card, which transfers all relevant data to the mobile device via near-field radio communication (NFC) or optical QR codes. If the mobile device is within range of the additional module, this data transmission can take place in real time during an injection process or only after it has ended. In the former case, the mobile device can give instructions to the user in real time and guide them through the next steps. If necessary, the injection information can also be saved on the additional module and only transferred later in consolidated form.
- the data received from the mobile device can be supplemented by the user, for example by specifying the injection site, and is passed on to the expert system in an appropriate way. The latter stores the data and provides patients, medical staff and health insurers with targeted information, thereby supporting compliance with a therapy plan by the user of the injection device.
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Description
Die vorliegende Erfindung betrifft das Gebiet der medizinischen Injektionsgeräte zur Verabreichung von flüssigen Substanzen, insbesondere von Medikamenten oder medizinischen Substanzen wie Insulin- und Hormonpräparationen. Die Erfindung bezieht sich auf ein medizinisches Überwachungssystem mit einem portablen elektronischen Zusatzmodul zum Aufsetzen auf ein Injektionsgerät.The present invention relates to the field of medical injection devices for administering liquid substances, in particular medications or medical substances such as insulin and hormone preparations. The invention relates to a medical monitoring system with a portable electronic additional module for attaching to an injection device.
Die Patentanmeldung
Die Patentanmeldung
Der Begriff "Medikament" oder "medizinische Substanz" umfasst in diesem Zusammenhang jede fliessfähige medizinische Formulierung, welche geeignet ist zur kontrollierten Verabreichung mittels einer Kanüle oder Hohlnadel, beispielsweise eine Flüssigkeit, eine Lösung, ein Gel oder eine feine Suspension enthaltend einen oder mehrere medizinische Wirkstoffe. Ein Medikament kann also eine Zusammensetzung mit einem einzigen Wirkstoff oder eine vorgemischte oder co-formulierte Zusammensetzung mit mehreren Wirkstoffen aus einem einzelnen Behälter sein. Der Begriff umfasst insbesondere Arzneien wie Peptide (z.B. Insuline, Insulin enthaltende Medikamente, GLP-1 enthaltende sowie abgeleitete oder analoge Zubereitungen), Proteine und Hormone, biologisch gewonnene oder aktive Wirkstoffe, Wirkstoffe auf Basis von Hormonen oder Genen, Nährformulierungen, Enzyme und weitere Substanzen sowohl in fester (suspendierter) oder flüssiger Form. Der Begriff umfasst weiter auch Polysaccharide, Vakzine, DNS oder RNS oder Oligonukleotide, Antikörper oder Teile von Antikörpern sowie geeignete Basis-, Hilfs- und Trägerstoffe.The term “medication” or “medical substance” in this context includes any flowable medical formulation that is suitable for controlled administration using a cannula or hollow needle, for example a liquid, a solution, a gel or a fine suspension containing one or more medicinal active ingredients . A drug may therefore be a single active ingredient composition or a premixed or co-formulated multi-active ingredient composition from a single container. The term includes in particular drugs such as peptides (e.g. insulins, insulin-containing drugs, GLP-1-containing and derived or analogous preparations), proteins and hormones, biologically derived or active active ingredients, active ingredients based on hormones or genes, nutritional formulations, enzymes and other substances both in solid (suspended) or liquid form. The term also includes polysaccharides, vaccines, DNA or RNA or oligonucleotides, antibodies or parts of antibodies as well as suitable base, auxiliary and carrier materials.
Es ist eine Aufgabe der Erfindung, eine einfache und kostengünstige Möglichkeit zur Überwachung oder Kontrolle auf korrekte Ausführung eines mit einem automatischen Injektionsgerät durchgeführten Injektionsvorgangs und zur Weiterleitung der injektionsrelevanten Daten zu schaffen. Es ist eine weitere Aufgabe der Erfindung, ein sicheres Zusammenwirken von Komponenten, Geräten und Systemen zur Erzeugung, Sammlung, und Verteilung von Daten im Zusammenhang mit dem Einsatz von Injektionsgeräten zu ermöglichen.It is an object of the invention to create a simple and cost-effective way to monitor or control the correct execution of an injection process carried out with an automatic injection device and to forward the injection-relevant data. It is a further object of the invention to enable safe interaction of components, devices and systems for generating, collecting and distributing data in connection with the use of injection devices.
Diese Aufgabe wird gelöst mit Hilfe eines elektronischen Zusatzmoduls welches vor Injektionsbeginn auf ein automatisches Injektionsgerät mit einer Längsachse, welche ein proximales Ende und ein distales oder einstechseitiges Ende des Injektionsgerätes verbindet, lösbar aufgesetzt oder aufgesteckt wird. Erfindungsgemäss umfasst das Zusatzmodul einen Kraftsensor zur Messung einer durch das Injektionsgerät auf das aufgesetzte Zusatzmodul während eines Injektionsvorgangs ausgeübten oder übertragenen zeitveränderlichen axialen Kraftkomponente in Richtung der Längsachse. Erfindungsgemäss umfasst das Zusatzmodul einen Griff oder eine bevorzugte Griffposition zum Ergreifen und Halten des Injektionsgerätes und des aufgesetzten Zusatzmoduls, beziehungsweise des Zusatzmoduls und des eingesetzten Injektionsgerätes. Der Griff kann ein zur Ergreifung durch eine Hand eines Benutzers des Injektionsgerätes ergonomisch vorgeformter Teil eines Modulgehäuses des Zusatzmoduls sein, so dass alle weiteren im gekoppelten Zustand sichtbaren Bereiche des Zusatzmoduls und des Injektionsgerätes einem Benutzer als deutlich weniger geeignet zur Ergreifung erscheinen. Ein Benutzer welcher das Injektionsgerät ausschließlich über den Griff des aufgesetzten Zusatzmoduls ergreift kann keine Kräfte direkt auf das Injektionsgerät einleiten oder aus dem Injektionsgerät ausleiten. Insbesondere werden im statischen Gleichgewicht vergleichbare Axialkräfte an der Einstechstelle und über das Zusatzmodul auf das Injektionsgerät übertragen, so dass der Kraftsensor im Zusatzmodul nicht nur ein Vibrationsverhalten des Injektionsgerätes detektieren sondern auch eine konstante oder nur langsam veränderliche, keine Beschleunigung erzeugende axiale Krafteinleitung durch den Benutzer messen kann.This task is solved with the help of an additional electronic module which, before the start of the injection, is releasably placed or plugged onto an automatic injection device with a longitudinal axis which connects a proximal end and a distal or puncture-side end of the injection device. According to the invention, the additional module comprises a force sensor for measuring a time-varying axial force component in the direction of the longitudinal axis that is exerted or transmitted by the injection device to the attached additional module during an injection process. According to the invention, the additional module comprises a handle or a preferred grip position for gripping and holding the injection device and the attached additional module, or the additional module and the inserted injection device. The handle can be a part of a module housing of the additional module that is ergonomically preformed so that it can be grasped by a hand of a user of the injection device, so that all other areas of the additional module and the injection device that are visible in the coupled state appear to a user as significantly less suitable for grasping. A user who only grips the injection device using the handle of the attached additional module cannot introduce any forces directly onto the injection device or remove them from the injection device. In particular, in static equilibrium, comparable axial forces are transmitted to the injection device at the puncture point and via the additional module, so that the force sensor in the additional module not only detects a vibration behavior of the injection device but also measures a constant or only slowly changing axial force introduction by the user that does not produce any acceleration can.
Das Zusatzmodul umfasst ein hülsenförmiges Modulgehäuse mit einer Geräteaufnahme oder Öffnung, in welche das Injektionsgerät vor Injektionsbeginn eingesetzt wird und welche im aufgesetzten Zustand das Injektionsgerät zumindest teilweise umgibt. Der Griff ist ebenfalls Teil des Modulgehäuses und umgibt die Geräteaufnahme, zudem weist der Griff in Richtung der Längsachse eine Ausdehnung von mindestens einer halben Handbreite eines Benutzers auf, insbesondere eine Ausdehnung von mindestens fünf oder mindestens acht cm. Der Griff ist also radial ausserhalb der Geräteaufnahme vorgesehen, was zu einer kompakteren Form führt als ein axial oder seitlich über das Injektionsgerät hinausreichender Ansatz am Zusatzmodul. Eine lichte Weite der Geräteaufnahme ist zumindest im Bereich des Griffs etwas grösser als ein Aussendurchmesser des Injektionsgerätes, so dass auch bei maximalem Griffdruck die Geräteaufnahme nicht auf das Injektionsgerät gepresst wird und keine Reibungs- oder Haltekräfte in Längsrichtung über die Geräteaufnahme zwischen Injektionsgerät und Zusatzmodul, unter Umgehung des Kraftsensors, übertragen werden.The additional module comprises a sleeve-shaped module housing with a device receptacle or opening into which the injection device is inserted before the start of the injection and which at least partially surrounds the injection device in the attached state. The handle is also part of the module housing and surrounds the device holder, and the handle also has an extension in the direction of the longitudinal axis of at least half the width of a user's hand, in particular an extension of at least five or at least eight cm. The handle is therefore provided radially outside the device holder, which leads to a more compact shape than an extension on the additional module that extends axially or laterally beyond the injection device. A clear width of the device holder is, at least in the area of the handle, slightly larger than an outer diameter of the injection device, so that even at maximum handle pressure, the device holder is not pressed onto the injection device and no friction or holding forces are created in the longitudinal direction over the device holder between the injection device and the additional module Bypassing the force sensor.
In einer weiter bevorzugten Ausführungsform weist das Zusatzmodul einen lösbaren Haltemechanismus auf, welcher im aufgesetzten Zustand eine Bewegung des Zusatzmoduls relativ zum Injektionsgerät in Richtung der Längsachse einschränkt oder gar verunmöglicht. Durch eine Begrenzung der Relativbewegung in axialer Richtung können die während der Injektion auf den Kraftsensor in proximaler Richtung einwirkenden Kräfte begrenzt werden. Durch den Haltemechanismus sind Injektionsgerät und Zusatzmodul gegen unbeabsichtigtes Entkoppeln gesichert, und die bei einer Nadelschutzkappenentfernung in distaler Richtung auf das Zusatzmodul wirkenden Kraftspitzen können über das Zusatzmodul abgeleitet werden.In a further preferred embodiment, the additional module has a releasable holding mechanism which, when attached, restricts or even makes movement of the additional module relative to the injection device in the direction of the longitudinal axis. By limiting the relative movement in the axial direction, the forces acting on the force sensor in the proximal direction during the injection can be limited. The holding mechanism secures the injection device and additional module against unintentional decoupling, and the force peaks acting on the additional module in the distal direction when the needle cap is removed can be diverted via the additional module.
Das Zusatzmodul weist eine Auswerteelektronik auf, konfiguriert zur Identifikation von Vorgängen im, oder von Zuständen des, Injektionsgerätes während eines Injektionsvorganges, basierend auf Messungen des Kraftsensors, insbesondere basierend auf deutlichen Änderungen der Axialkraft hervorgerufen durch Bewegungen des Benutzers oder durch einen freigegebenen Antriebsmechanismus. Beispielsweise kann die Detektion eines Anstiegs der gemessenen axialen Kraftkomponente auf einen während einer gewissen Minimalinjektionszeit eine minimale Haltekraft nicht unterschreitenden Wert und eines nachfolgenden Abfalls der Axialkraft auf null von der Auswerteelektronik als Kraftaufwand eines Benutzers zwischen Einstechvorgang und Injektionsgeräteentfernung mit entsprechender Bewegung einer Nadelschutzhülse samt Druckbeaufschlagung einer zugehörigen Nadelschutzhülsenfeder identifiziert werden. Weiter können überlagernde Bewegungen von Komponenten des Injektionsgerätes, wie ein Drehen einer Hülse oder ein Auslenken eines Schnappers zur Verriegelung oder Entriegelung zu einem identifizierbaren, zeitlich begrenzten Anstieg oder Abfall in der gemessenen Axialkraft führen.The additional module has evaluation electronics, configured to identify processes in, or states of, the injection device during an injection process, based on measurements of the force sensor, in particular based on significant changes in the axial force caused by movements of the user or by an enabled drive mechanism. For example, the detection of an increase in the measured axial force component to a value that does not fall below a minimum holding force during a certain minimum injection time and a subsequent drop in the axial force to zero can be seen by the evaluation electronics as the effort exerted by a user between the piercing process and removal of the injection device with a corresponding movement of a needle protection sleeve including pressurization of an associated one Needle protection sleeve spring can be identified. Furthermore, superimposed movements of components of the injection device, such as turning a sleeve or deflecting a snapper for locking or unlocking, can lead to an identifiable, time-limited increase or decrease in the measured axial force.
In einer Weiterentwicklung dieser vorteilhaften Variante werden auch kurzzeitige Kraftstösse von wenigen Millisekunden Dauer und resultierend aus automatischen, federgetriebenen Bewegungen eines Anschlagelementes des Injektionsgerät zur Signalisierung eines Ausschüttbeginns oder eines Ausschüttendes registriert oder festgestellt. Die gemessenen Kraftstösse können beispielsweise rasch abklingende Schwingungen oder Vibrationen des Injektionsgerätes relativ zum Zusatzmodul entsprechen. Insbesondere wird ein Beginn der Ausschüttung durch eine korrelierte Messung eines schnellen Anstiegs der Axialkraft auf einen Haltekraftwert und eines deutlichen Kraftstosses identifiziert, während ein Ende der Ausschüttung durch Messung eines Kraftstoss in Kombination mit einer konstanten axialen Haltekraft identifiziert wird. Bevorzugt umfasst die Signalisierung eine ungebremste Beschleunigungsphase des Anschlagelementes und einen nachfolgenden Anschlag oder Aufprall des Anschlagelementes zur Anregung von Schwingung im Injektionsgerät, welche primär durch den Benutzer als akustisches oder taktiles Klick-Signal wahrgenommen werden können und zusätzlich auch durch einen geeignet platzierten Axialkraftsensor messbar sind.In a further development of this advantageous variant, short-term force surges lasting a few milliseconds and resulting from automatic, spring-driven movements of a stop element of the injection device are also registered or detected to signal the start or end of distribution. The measured force impulses can, for example, decay quickly Oscillations or vibrations of the injection device relative to the additional module correspond. In particular will a start of the distribution is identified by a correlated measurement of a rapid increase in the axial force to a holding force value and a clear force surge, while an end of the distribution is identified by measuring a force surge in combination with a constant axial holding force. The signaling preferably includes an unbraked acceleration phase of the stop element and a subsequent stop or impact of the stop element to stimulate vibration in the injection device, which can be perceived primarily by the user as an acoustic or tactile click signal and can also be measured by a suitably placed axial force sensor.
In einer vorteilhaften Weiterentwicklung wird ein kurzzeitiges Kraftstosssignal des Kraftsensors gefiltert und in einem Komparator oder einer Vergleichsschaltung mit einem ersten und bevorzugt einem zweiten oder weiteren Schwellwert verglichen und in ein mehrwertiges, insbesondere zwei- oder dreiwertiges diskretes Ereignismuster im Ausgangssignal des Komparators überführt. Stimmt ein derart ermitteltes Ereignismuster mit einem vorbestimmten und gespeicherten Basismuster überein, welches ein bestimmtes Basisereignis charakterisiert, wird das ursprüngliche Kraftstosssignal als zu dem bestimmten Basisereignis gehörig identifiziert. Es wird also ausgenutzt, dass ein Basisereignis, also beispielsweise ein Anschlag eines Anschlagelementes zur Signalisierung eines Ausschüttbeginns oder eines Ausschüttendes, über ein charakteristisches mehrwertiges Basismuster im Axialkraft-Ausgangssignal des Komparators verfügt, welches sich in jedem Ereignismuster eines einmalig registrierten Anschlagsereignisses wiederfindet.In an advantageous further development, a short-term force impulse signal from the force sensor is filtered and compared in a comparator or a comparison circuit with a first and preferably a second or further threshold value and converted into a multi-valued, in particular two- or three-valued, discrete event pattern in the output signal of the comparator. If an event pattern determined in this way matches a predetermined and stored base pattern that characterizes a specific base event, the original force impulse signal is identified as belonging to the specific base event. It is therefore taken advantage of the fact that a basic event, for example a stop of a stop element for signaling a start or end of distribution, has a characteristic multi-valued basic pattern in the axial force output signal of the comparator, which is reflected in every event pattern of a one-time registered stop event.
In einer alternativen Weiterentwicklung der vorteilhaften Variante weist das Zusatzmodul ein Mikrofon oder akustischen Sensor auf zur Messung eines akustischen Signals während des Injektionsvorganges, insbesondere von durch die Luft übertragenen Schwingungen des Injektionsgerätes. Die Auswerteelektronik identifiziert in diesem Fall das Ereignis basierend auf Messungen des Mikrofons und Messungen des Kraftsensors. Beispielsweise wird ein Beginn der Ausschüttung durch eine korrelierte Messung eines schnellen Anstiegs der Axialkraft auf einen Haltekraftwert und eines deutlichen akustischen Signals identifiziert, während ein Ende der Ausschüttung durch Messung eines deutlichen akustischen Signals in Kombination mit einer konstanten axialen Haltekraft bestimmt wird.In an alternative further development of the advantageous variant, the additional module has a microphone or acoustic sensor for measuring an acoustic signal during the injection process, in particular vibrations of the injection device transmitted through the air. In this case, the evaluation electronics identify the event based on measurements from the microphone and measurements from the force sensor. For example, a start of the distribution is identified by a correlated measurement of a rapid increase in the axial force to a holding force value and a clear acoustic signal, while an end of the distribution is determined by measuring a clear acoustic signal in combination with a constant axial holding force.
Als Alternativen zum Mikrofon können auch ein einachsiger oder ein mehrachsiger Beschleunigungssensor oder ein Gyroskop eingesetzt werden. Bei diesen Alternativen wie auch beim Mikrofon ist die Platzierung des Sensors im Zusatzmodul gegenüber dem auf eine Kontaktfläche zum Injektionsgerät angewiesenen Kraftsensor weniger kritisch. In diesen Weiterentwicklungen wird also durch das Zusatzmodul einerseits eine axiale, insbesondere konstante, Mindestkraft des Benutzers auf das Injektionsgerät kontinuierlich gemessen, und andererseits eine zweite Messung mit einem von dem Kraftsensor verschiedenen Sensortyp durchgeführt, wobei die beiden Messungen gemeinsam zur Ereignisidentifikation ausgewertet werden.A single-axis or multi-axis acceleration sensor or a gyroscope can also be used as alternatives to the microphone. With these alternatives, as with the microphone, the placement of the sensor in the additional module is less critical compared to the force sensor, which relies on a contact surface with the injection device. In these further developments, the additional module continuously measures, on the one hand, an axial, in particular constant, minimum force of the user on the injection device, and, on the other hand, carries out a second measurement with a sensor type different from the force sensor, with the two measurements being evaluated together for event identification.
Ein Zustand des Injektionsgerätes oder ein Prozess eines Injektionsvorganges kann also vom Zusatzmodul allein auf der Basis der Messungen des Axialkraftsensors, optional ergänzt durch Messungen eines zweiten Sensors, ermittelt werden. Tatsächlich ist eine aufwändige Detektion einer eingestellten oder ausgeschütteten Dosis für eine aussagekräftige Zustands- oder Prozessermittlung vielfach weder möglich noch erforderlich. Ein Injektionsvorgang kann auf Basis der drei Ereignisse Einstechen/Beginn Ausschüttung, Ende Ausschüttung, und Geräteentfernung als korrekt abgelaufen eingestuft werden. Sollte die Reihenfolge dieser Ereignisse oder eine Zeitspanne dazwischen nicht den Erwartungen entsprechen kann vom Zusatzmodul eine entsprechende Meldung erzeugt werden.A state of the injection device or a process of an injection process can therefore be determined by the additional module solely on the basis of the measurements of the axial force sensor, optionally supplemented by measurements from a second sensor. In fact, it is a complex detection of a discontinued or released Dose is often neither possible nor necessary for a meaningful determination of the status or process. An injection process can be classified as having taken place correctly based on the three events of piercing/start of distribution, end of distribution, and device removal. If the order of these events or a period of time in between does not correspond to expectations, the additional module can generate a corresponding message.
Ein Zusatzmodul nach der Erfindung kann in vorteilhafter Weise wiederholt eingesetzt werden zur Überwachung eines Gebrauchs oder Einsatzes von automatischen Einweg-Injektionsgeräten oder Autoinjektoren. Insbesondere ist das Zusatzmodul geeignet für einen Retrofit-Einsatz bei existierenden Injektionsgeräten, welche für eine Anpassung oder Modifikation nicht zur Verfügung stehen. In dieser Konfiguration sind im Injektionsgerät keine Sensoren vorgesehen zur Erfassung oder Bearbeitung von Sensordaten über die Operation des Gerätes, ebenso wenig eine Kommunikationsschnittstelle zur Übermittlung dieser Daten an einen Empfänger. Dementsprechend müssen die Kraftsensoren im Zusatzgerät derart ausgestaltet und positioniert werden, dass sie Zustandsänderungen oder Primärsignale von innerhalb des Injektionsgerätes feststellen können.An additional module according to the invention can advantageously be used repeatedly to monitor the use or use of automatic disposable injection devices or auto-injectors. In particular, the additional module is suitable for retrofitting existing injection devices that are not available for adaptation or modification. In this configuration, no sensors are provided in the injection device for acquiring or processing sensor data about the operation of the device, nor is there a communication interface for transmitting this data to a receiver. Accordingly, the force sensors in the additional device must be designed and positioned in such a way that they can detect changes in state or primary signals from within the injection device.
In einer weiteren Ausführungsform der Erfindung umfasst das Zusatzmodul eine Kommunikationseinheit zur drahtlosen Kommunikation mit einem mobilen Gerät, beispielsweise einem Mobiltelefon oder Smartphone, und/oder einen optischen, akustischen, oder taktilen Zustandsanzeiger. Ein angezeigter Zustand oder Status des Systems kann einen Gerätezustand des Injektionsgerätes, einen Modulzustand des Zusatzmoduls, oder einen Vorgangszustand eines laufenden oder abgeschlossenen Injektionsvorganges umfassen. Der Zustandsanzeiger kann einfach gehalten werden und sich auf einige wenige LEDs beispielsweise in Ampelfarben und/oder einen akustischen Signalgenerator zur Erzeugung von sprachunabhängigen Geräuschen oder Melodien beschränken. Dies ist insbesondere im Zusammenwirken mit den fortgeschrittenen graphischen Anzeigemöglichkeiten und Sprachausgabemöglichkeiten eines Smartphones vorteilhaft, da das drahtlos an das Zusatzmodul gekoppelte Smartphone die verfeinerte, über eine Statusanzeige hinausgehende Kommunikation mit dem Benutzer übernimmt. Die Zustandsinformation kann eine Angabe zum Ablauf einer Haltezeit oder Wartezeit umfassen, welche der Benutzer nach abgeschlossener Ausschüttung abwarten muss bevor das Injektionsgerät von der Injektionsstelle sicher entfernt werden kann. Eine einfache Erfassung der seit dem festgestellten Ausschüttende verflossenen Zeit und ein Vergleich mit einer Solldauer erlaubt es dem Benutzer den Zeitpunkt zum sicheren Entfernen des Injektionsgerätes anzeigen. Dies kann sowohl durch ein Zusatzmodul mit Zeiterfassungsfunktion als auch durch ein mit Echtzeit-Ereignisübertragung an das Zusatzmodul gekoppeltes mobiles Gerät erfolgen.In a further embodiment of the invention, the additional module comprises a communication unit for wireless communication with a mobile device, for example a cell phone or smartphone, and/or an optical, acoustic, or tactile status indicator. A displayed state or status of the system can include a device state of the injection device, a module state of the additional module, or a process state of an ongoing or completed injection process. The status indicator can be kept simple and limited to a few LEDs, for example in traffic light colors, and/or an acoustic signal generator to generate speech-independent noises or melodies. This is particularly advantageous in conjunction with the advanced graphical display options and voice output options of a smartphone, since the smartphone, which is wirelessly coupled to the additional module, takes over the refined communication with the user that goes beyond a status display. The status information can include information about the expiration of a holding time or waiting time, which the user must wait after the delivery has been completed before the injection device can be safely removed from the injection site. A simple recording of the time that has elapsed since the end of the discharge was determined and a comparison with a target duration allows the user to see the time to safely remove the injection device. This can be done both by an additional module with a time recording function and by a mobile device coupled to the additional module with real-time event transmission.
Für den Fachmann sind direkt und offensichtlich weitere Ausführungsformen und Ausgestaltungen erkennbar, welche sich aus Kombinationen der beschriebenen Beispiele oder Kombinationen der beschriebenen Beispiele mit dem allgemeinen Fachwissen des Fachmanns ergeben.Further embodiments and refinements can be directly and obviously recognized by the person skilled in the art, which result from combinations of the examples described or combinations of the examples described with the general specialist knowledge of the person skilled in the art.
In Zusammenhang mit den angehängten Figuren werden nachfolgend bevorzugte Ausführungsformen der Erfindung beschrieben. Diese sollen grundsätzliche Möglichkeiten der Erfindung aufzeigen und keinesfalls einschränkend ausgelegt werden.
-
Fig.1 zeigt ein Injektionssystem mit einem Injektionsgerät und einem Zusatzmodul; -
Fig.2 zeigt eine Injektionsvorrichtung im Längsschnitt; -
Fig.3 zeigt eine Explosionsdarstellung eines Zusatzmoduls; -
Fig.4 zeigt gemessene Signale eines Kraftsensors und eines Mikrofons im Zusatzmodul; -
Fig.5 zeigt ein Schema für eine Auswerteelektronik eines Zusatzmoduls; -
Fig.6 zeigt ein durch einen Kraftsensor gemessenes und gefiltertes Signal; -
Fig.7 zeigt eine Ereignismusterbildung aus einem Kraftstosssignal; und -
Fig.8 zeigt ein erweitertes medizinisches Überwachungssystem.
-
Fig.1 shows an injection system with an injection device and an additional module; -
Fig.2 shows an injection device in longitudinal section; -
Fig.3 shows an exploded view of an additional module; -
Fig.4 shows measured signals from a force sensor and a microphone in the additional module; -
Fig.5 shows a diagram for an evaluation electronics of an additional module; -
Fig.6 shows a signal measured and filtered by a force sensor; -
Fig.7 shows an event pattern formation from a force impulse signal; and -
Fig.8 shows an advanced medical monitoring system.
Zu Beginn einer Injektion wird das distale Ende des Injektionsgerätes, also die Nadelschutzhülse, durch den Benutzer auf die Einstechstelle gedrückt so dass die Nadelschutzhülse unter Spannung der Nadelschutzhülsenfeder in proximale Richtung in das Injektionsgerät eingeschoben wird und gleichzeitig die Nadel in die Einstechstelle eindringt. Um sicherzustellen dass in jedem Fall der Benutzer die Kraft während dem gesamten Injektionsvorgang inklusive Auslösung und Durchführung der Ausschüttung mittels Zusatzmodul auf das Injektionsgerät überträgt ist das Zusatzmodul als Hülse über einen Großteil des Injektionsgerätes ausgebildet. Das Injektionsgerät kann damit nicht unbeabsichtigt gehalten werden. Eine lichte Weite oder ein Innendurchmesser der Geräteaufnahme ist zumindest im Bereich des Griffs um einen über den Fertigungstoleranzen liegenden Betrag von wenigen Zehntels Millimeter grösser als ein Aussendurchmesser des Injektionsgerätes. Das Zusatzmodul weist radial also etwas Spiel zum Injektionsgerät auf, damit diese sich reibungsfrei zueinander bewegen können und die gesamte Kraft über den Kraftsensor übertragen wird.At the beginning of an injection, the distal end of the injection device, i.e. the needle protection sleeve, is pressed onto the injection site by the user so that the needle protection sleeve is pushed into the injection device in the proximal direction under tension of the needle protection sleeve spring and at the same time the needle penetrates the injection site. To ensure that in any case the user has the power during the The entire injection process, including triggering and carrying out the distribution, is transferred to the injection device using an additional module, the additional module is designed as a sleeve over a large part of the injection device. This means that the injection device cannot be held unintentionally. A clear width or an inside diameter of the device holder is, at least in the area of the handle, larger than an outside diameter of the injection device by an amount of a few tenths of a millimeter that exceeds the manufacturing tolerances. The additional module has some play radially relative to the injection device so that they can move towards each other without friction and the entire force is transmitted via the force sensor.
Alternativ zum gleichzeitigen Nadelschutzhülseneinschub und Nadeleinstechen kann eine im Injektionsgerät schiebbar gelagerte Spritze, welche im Auslieferungszustand inklusive Nadelspitze vollständig vom Gerätegehäuse umfasst ist, durch die Kraft einer Einstech- und/oder Ausschüttfeder relativ zum Gerätegehäuse bewegt werden. Diese automatisierte Einstechbewegung wird nach einem teilweisen oder vollständigen Einschieben der Nadelschutzhülse in das Injektionsgerät ausgelöst, ein Aufprall der beschleunigten Spritze auf ein Anschlagelement bewirkt ebenfalls einen deutlichen Kraftstoss gefolgt von einer annähernd konstanten Halte- oder Ausschüttkraft. Die vorhergehende Einschubbewegung der Nadelschutzhülse mit gleichzeitigem Spannen der Nadelschutzhülsenfeder kann dabei langsam erfolgen, im Falle einer vorgespannten Nadelschutzhülsenfeder möglicherweise erst nach Überwindung einer Federvorspannkraft. Die Bewegung kann einen kontinuierlichen Anstieg der gemessenen Axialkraft zur Folge haben, eventuell unter Aufwendung einer im Kraftverlauf sichtbaren und der Federkompressionskraft überlagerten minimalen Entriegelungs- oder Injektionssperrkraft. In einer weiteren Ausführungsform kann die Einstechbewegung auch durch einen vom Benutzer zu betätigenden Auslöseknopf gestartet werden.As an alternative to the simultaneous needle protection sleeve insertion and needle insertion, a syringe that is slidably mounted in the injection device, which in the delivery state is completely enclosed by the device housing including the needle tip, can be moved relative to the device housing by the force of an insertion and/or ejection spring. This automated piercing movement is triggered after the needle protection sleeve has been partially or completely inserted into the injection device. An impact of the accelerated syringe on a stop element also causes a significant surge of force followed by an approximately constant holding or dispensing force. The previous insertion movement of the needle protection sleeve with simultaneous tensioning of the needle protection sleeve spring can take place slowly, in the case of a preloaded needle protection sleeve spring possibly only after a spring preload force has been overcome. The movement can result in a continuous increase in the measured axial force, possibly with the application of a minimum unlocking force that is visible in the force curve and superimposed on the spring compression force Injection locking force. In a further embodiment, the piercing movement can also be started by a trigger button that can be activated by the user.
Eine Haltevorrichtung oder ein Haltemechanismus umfasst ein in der Modulhülse geführtes ringförmiges Übertragungselement 24b, eine fest am Übertragungselement angeordnete Haltestruktur oder Nase, eine Einrastfeder welche das Übertragungselement mit der Haltestruktur in eine Halteposition bewegt, und ein Löseknopf als Betätigungselement 24a zur Bewegung des Übertragungselements und zur Lösung der Haltestruktur aus der Halteposition. Die Haltestruktur ist in der Halteposition in eine Vertiefung wie etwa eine Kerbe oder ein Schlitz des Gehäuses des Injektionsgerätes eingerastet. Diese Vertiefung kann auch für andere Zwecke nutzbar sein und ist idealerweise in bestehenden Injektionsgeräten bereits vorhanden, wodurch am Injektionsgerät zum Einsatz des Zusatzmoduls keine Anpassung vorgenommen werden muss. Alternativ zur Druckbeaufschlagung des Löseknopfs und einer Bewegung des Übertragungselements senkrecht zur Längsachse kann das Betätigungselement auch eine schiebende Bewegung ausführen. Bei gelöster Haltestruktur kann das Injektionsgerät aus dem Zusatzmodul in axialer Richtung herausgleiten, der Haltemechanismus ermöglicht also ein lösbares Aufschnappen des Zusatzmoduls auf das Injektionsgerät. Das Modulgehäuse in
Die Haltevorrichtung kann durch entsprechende Ausbildung von Haltestruktur und Vertiefung in axialer Richtung etwas Spiel aufweisen, so dass sich der Kraftsensor von der Endkappe oder Kontaktfläche weg bewegen kann. In diesem Fall fehlt eine Vorspannung des Kraftsensors wenn das Injektionsgerät nicht auf die Injektionsstelle aufgesetzt und die Nadelschutzhülsenfeder nicht komprimiert ist. Entsprechend kann ein Signal oder Klick am Ende der Ausschüttung nach vorzeitiger Entfernung des Injektionsgerätes möglicherweise durch den Kraftsensor nicht mehr erkannt werden, so dass nur eine akustische Identifikation über das Mikrofon zur Vervollständigung des fehlerhaften Injektionsvorgangs beitragen kann. Andererseits kann durch kraftschlüssiges Einschnappen der Haltestruktur des Zusatzmoduls in die Vertiefung des Injektionsgerätes der Kraftsensor auch vorbelastet oder vorgespannt sein. In diesem Fall ist eine Vorspannstrecke im Modulgehäuse zwischen Haltevorrichtung und Kraftsensor entsprechend auf Zug vorbelastet, und unter Umständen sind erst externe Axialkräfte über einem gewissen Vorspannwert am Kraftsensor beobachtbar. So misst ein an der proximalen Stirnfläche des Injektionsgeräts anliegender Kraftsensor initial den Vorspannwert sowie jede beliebig kleine Benutzerkraft, welche unter Umgehung der Vorspannstrecke beispielsweise nach hinten abgeleitet wird. Andererseits wird bei der bevorzugten Anordnung des Griffs als Teil des die Geräteaufnahme umgebenden Modulgehäuses ein Teil der Axialkraft des Benutzers zumindest teilweise über die Vorspannstrecke auf den Kraftsensor geleitet. Dadurch wird zuerst die Zugbelastung in der Vorspannstrecke reduziert, und nur Benutzerkräfte oberhalb eines die Vorspannkraft nicht überschreitenden Minimalwertes werden durch den Kraftsensor zusätzlich zur Vorspannkraft gemessen.By appropriately designing the holding structure and recess, the holding device can have some play in the axial direction, so that the force sensor can move away from the end cap or contact surface. In this case, there is no preload on the force sensor if the injection device is not on the Injection site is in place and the needle protection sleeve spring is not compressed. Accordingly, a signal or click at the end of the delivery may no longer be recognized by the force sensor after the injection device has been removed prematurely, so that only acoustic identification via the microphone can contribute to completing the incorrect injection process. On the other hand, the force sensor can also be preloaded or prestressed by force-fitting snapping of the holding structure of the additional module into the recess of the injection device. In this case, a prestressing section in the module housing between the holding device and the force sensor is correspondingly preloaded in tension, and under certain circumstances external axial forces can only be observed on the force sensor above a certain prestressing value. A force sensor placed on the proximal end face of the injection device initially measures the preload value as well as any small user force, which is diverted backwards, for example, bypassing the preload path. On the other hand, in the preferred arrangement of the handle as part of the module housing surrounding the device holder, part of the user's axial force is at least partially directed to the force sensor via the preload path. This first reduces the tensile load in the pre-tensioning section, and only user forces above a minimum value that does not exceed the pre-tensioning force are measured by the force sensor in addition to the pre-tensioning force.
In der gezeigten Ausführungsform kommt der Axialkraftsensor im aufgesetzten Zustand des Zusatzmoduls am proximalen, oder hinteren, Ende des Injektionsgerätes zu liegen. Er berührt also eine proximale Stirnfläche oder Endkappe des Injektionsgerätes, was gegenüber einer Kraftübertragung über eine seitlich am Gerät vorzusehende Kontaktfläche senkrecht zur Achse, also beispielsweise über eine proximale Ringfläche eines umlaufenden Flansches oder eines Abschnittes davon, eine Vereinfachung darstellt. Ebenso ist eine Umleitung der Axialkraft mittels beweglicher Komponenten am Zusatzmodul in eine von der Längsrichtung abweichende Richtung denkbar, etwa für eine nicht-axiale Platzierung des Kraftsensors.In the embodiment shown, the axial force sensor comes to rest at the proximal, or rear, end of the injection device when the additional module is in place. It therefore touches a proximal end face or end cap of the injection device, which represents a simplification compared to force transmission via a contact surface to be provided on the side of the device perpendicular to the axis, for example via a proximal annular surface of a circumferential flange or a section thereof. It is also conceivable to redirect the axial force by means of movable components on the additional module in a direction that deviates from the longitudinal direction, for example for non-axial placement of the force sensor.
Geeignete Kraftsensoren basieren auf einem piezoresistiven Effekt, also auf einer Änderung des spezifischen elektrischen Widerstandes eines Leiters bei mechanischer Verformung. Bei Kraftsensoren der FSS Serie des Anbieters Honeywell erhöht sich ein Widerstand von in einem Silizium-Messelement integrierten Piezowiderständen, wenn diese durch Kraftaufwand gebogen werden, was über eine Widerstandsbrücke messbar ist. Der Sensor überträgt eine angewendete Kraft zwischen null und 20 Newton über eine Edelstahlkugel direkt auf das Silizium-Messelement, wobei die Kugel um einen Hub von maximal 50 Mikrometer bewegt wird. Alternative Kraftsensoren zur Messung von Haltekräften umfassen auf Biegebalken angebrachte Dehnungsmessstreifen, oder FSR (Force Sensing Resistor) Drucksensoren.Suitable force sensors are based on a piezoresistive effect, i.e. on a change in the specific electrical resistance of a conductor when mechanically deformed. In force sensors from the FSS series from Honeywell, the resistance of piezoresistors integrated into a silicon measuring element increases when they are bent by force, which can be measured via a resistance bridge. The sensor transmits an applied force between zero and 20 Newtons directly to the silicon measuring element via a stainless steel ball, moving the ball by a maximum stroke of 50 micrometers. Alternative force sensors for measuring holding forces include strain gauges mounted on bending beams, or FSR (Force Sensing Resistor) pressure sensors.
Die Auswerteeinheit kann in der Kommunikationseinheit 23h integriert sein oder als eigenständiger Chip auf dem Elektronikhalter vorgesehen sein. Die Auswerteeinheit verarbeitet die Signale des Kraftsensors und der allenfalls vorgesehenen weiteren Sensoren, besorgt eine Zeitstempelung, und bestimmt aus den verarbeiteten Signalen und den zugehörigen Zeitstempeln eine konsolidierte Injektionsinformation. Letztere umfasst zumindest die Information dass eine Injektion zu einem bestimmten Zeitpunkt erfolgreich durchgeführt worden ist, oder welche Fehlhandlungen möglicherweise vorgenommen worden sind. Diese Information wird in einer Speichereinheit im Zusatzmodul gespeichert und/oder über die Kommunikationseinheit weitergeleitet. Die Speichereinheit kann auch Identifikationsdaten des Benutzers oder des Zusatzmoduls speichern.The evaluation unit can be integrated in the
Zu Energiesparzwecken kann der Kontaktschalter 23b auch als Aktivierungselement fungieren zur Aktivierung des Zusatzmoduls aus einem Stromsparmodus. Zusätzlich oder alternativ kann die Energiequelle wiederaufladbar sein, wozu das Zusatzmodul über einen geeigneten Stecker verfügt oder zur induktiven Energieübertragung von einer Ladestation vorgesehen ist. Die Ladestation kann ausschliesslich das Zusatzmodul aufnehmen, oder das Zusatzmodul mit eingesetztem Injektionsgerät, und kann auch von anderen aufladbaren Geräten des Benutzers mitbenutzt werden. Eine intelligente Ladestation kann als Basisstation fungieren und zusätzliche Funktionalitäten aufweisen, zum Beispiel eine Temperaturmessung des aufgenommenen Injektionsgerätes beziehungsweise des darin enthaltenen Medikamentes. Wird das Injektionsgerät nach einer Lagerung im Kühlschrank und vor dem Gebrauch im Ladegerät platziert kann eine solche Temperaturmessung am Injektionsgerät ein Signal ausgeben sobald eine Minimaltemperatur zur Verabreichung des Medikamentes erreicht ist. Während diesem Aufwärmvorgang kann auch die Energiequelle des Zusatzmoduls wiederaufgeladen werden, ohne weitere Intervention des Benutzers. Über eine weitere Kommunikationsschnittstelle kann die intelligente Ladestation kann auch Zeit und Datumsinformation zur Verfügung stellen zur Synchronisierung einer Uhr des Zusatzmoduls, oder als Rückfallebene zum mobilen Gerät wie unten beschrieben die konsolidierten Injektionsinformationen übernehmen.For energy saving purposes, the
Zustände, Vorgänge und Ereignisse im Injektionsgerät und während des Injektionsvorganges können durch kombinatorisches Verketten der Informationen des Kraftsensors und des Mikrofons exemplarisch wir folgt identifiziert werden. Zur Detektion eines Startklicks wird die Kombination eines deutlichen akustischen Peaks und eines Kraftanstiegs (mit Verbleib auf dem Kräfteplateau) gefordert. Um einen Endklick zu detektieren wird die Kombination eines deutlichen akustischen Peaks und einer konstant hoch bleibenden Kraft verlangt. Das Entfernen des Injektionsgerätes samt Zusatzmodul von der Injektionsstelle wird durch den Kraftabfall nach dem Endklick detektiert. Wird das Injektionsgerät vor dem Endklick oder auch während der geforderten Haltezeit von der Injektionsstelle entfernt, kann dies durch den vorzeitigen Kraftabfall detektiert werden.States, processes and events in the injection device and during the injection process can be identified by combinatorially linking the information from the force sensor and the microphone, as follows. To detect a start click, the combination of a clear acoustic peak and an increase in force (with remaining on the force plateau) is required. To detect a final click, the combination of a clear acoustic peak and a consistently high force is required. The removal of the injection device and additional module from the injection site is detected by the drop in force after the final click. If the injection device is removed from the injection site before the final click or during the required holding time, this can be detected by the premature drop in force.
Die Auswerteelektronik kann analog oder digital oder gemischt implementiert werden. Beispielsweise wird das hochpassgefilterte analoge Sensorsignal auf einen Mikroprozessor geführt, von diesem in ein digitales Signal umgewandelt und der digitalen, im Speicher des Mikroprozessors programmierten Komparatorfunktion zugeführt. Eine Abtastrate für die Digitalisierung des Kraftstosssignals muss gemäss Nyquist gewählt werden, für ein Kraftstosssignal entsprechend einem akustischen Klickgeräusch mit einem Frequenzspektrum bis 5 kHz ist also eine Abtastung alle 20 Mikrosekunden angebracht.The evaluation electronics can be implemented analog or digital or mixed. For example, the high-pass filtered analog sensor signal is fed to a microprocessor, converted by it into a digital signal and fed to the digital comparator function programmed in the microprocessor's memory. A sampling rate for the digitization of the force impulse signal must be selected according to Nyquist, so for a force impulse signal corresponding to an acoustic clicking noise with a frequency spectrum of up to 5 kHz, sampling every 20 microseconds is appropriate.
Das mobile Gerät muss initial eingerichtet und konfiguriert werden, etwa durch installieren einer Applikation und Registrierung des Benutzers. Dies kann durch eine Patientendatenkarte geschehen, welche über Nahfeldradiokommunikation (NFC) oder optische QR Codes alle relevanten Daten auf das mobile Gerät überspielt. Falls das mobile Gerät sich in Reichweite des Zusatzmoduls befindet kann diese Datenübertragung während einem Injektionsvorgang in Echtzeit erfolgen oder erst nach dessen Beendigung. Im erstgenannten Fall kann das mobile Gerät in Echtzeit Instruktionen an den Benutzer abgeben und diesen so durch die nächsten Schritte führen. Allenfalls können die Injektionsinformationen auch auf dem Zusatzmodul gespeichert werden und erst später, in konsolidierter Form, übertragen werden. Die vom mobilen Gerät empfangenen Daten können durch den Benutzer ergänzt werden, etwa durch Angabe der Injektionsstelle, und werden auf geeignetem Weg an das Expertensystem weitergegeben. Letzteres speichert die Daten und versorgt Patienten, medizinisches Personal, und Krankenversicherer mit gezielten Informationen und unterstützt so eine Befolgung eines Therapieplans durch den Benutzer des Injektionsgerätes.The mobile device must be initially set up and configured, for example by installing an application and registering the user. This can be done using a patient data card, which transfers all relevant data to the mobile device via near-field radio communication (NFC) or optical QR codes. If the mobile device is within range of the additional module, this data transmission can take place in real time during an injection process or only after it has ended. In the former case, the mobile device can give instructions to the user in real time and guide them through the next steps. If necessary, the injection information can also be saved on the additional module and only transferred later in consolidated form. The data received from the mobile device can be supplemented by the user, for example by specifying the injection site, and is passed on to the expert system in an appropriate way. The latter stores the data and provides patients, medical staff and health insurers with targeted information, thereby supporting compliance with a therapy plan by the user of the injection device.
- 11
- Injektionsgerätinjection device
- 1010
- GerätegehäuseDevice housing
- 10a10a
- FensterWindow
- 1111
- NadelschutzhülseNeedle protection sleeve
- 1212
- NadelschutzkappenentfernerNeedle cap remover
- 13a13a
- SpritzeInjection
- 13b13b
- Nadelneedle
- 1414
- NadelschutzhülsenfederNeedle protection sleeve spring
- 15a, 15b15a, 15b
- Anschlagelementstop element
- 1616
- Ausschüttfederdistribution spring
- 22
- ZusatzmodulAdditional module
- 2020
- ModulgehäuseModule housing
- 20a20a
- Öffnungopening
- 20b, 20c20b, 20c
- GehäusehälftenHousing halves
- 20d20d
- ModulhülseModule sleeve
- 2121
- GriffHandle
- 21a21a
- GriffbegrenzungGrip limitation
- 2222
- KraftsensorForce sensor
- 23a23a
- ElektronikhalterElectronics holder
- 23b23b
- KontaktschalterContact switch
- 23c23c
- VerbindungsanzeigeConnection indicator
- 23d23d
- ZustandsanzeigeStatus display
- 23e23e
- Mikrofonmicrophone
- 23f23f
- Batteriebattery
- 23g23g
- SummerBuzzer
- 23h11 p.m
- KommunikationseinheitCommunication unit
- 24a24a
- Löseknopfrelease button
- 24b24b
- ÜbertragungselementTransmission element
- 3131
- Mobiles GerätMobile device
- 3232
- DatenverarbeitungssystemData processing system
Claims (9)
- Injection system having an injection device (1), comprising- a needle protection sleeve (11) which is displaceable in a longitudinal direction between a proximal and a distal position;- a needle protection sleeve spring (14) which is coupled to the needle protection sleeve (11) and which, after substance delivery has taken place, pushes the needle protection sleeve (11) into the distal position, in which it laterally surrounds or shields the needle, the needle protection sleeve spring (14) being tensioned during a piercing process;
the injection system further comprising an add-on module (2) for attaching to the injection device (1), having a longitudinal axis, the add-on module (2) comprising- a force sensor (22) for measuring a force component, in the direction of the longitudinal axis, that is exerted by the injection device on the attached add-on module during an injection process;- an evaluation electronics system for evaluating measurements of the force sensor (22) for the purpose of identifying a process or a state of the injection device (1),characterized in that the add-on module (2) is designed to identify a piercing process from an increase in an axial force measured by the force sensor to an at least approximately constant value caused by the compressed needle protection sleeve spring, andthe add-on module (2) having a sleeve-shaped module housing having a device receptacle for receiving the injection device and a handle (21) for holding the injection device and the attached add-on module, a clear width of the device receptacle in the region of the handle being greater than an outer diameter of the injection device (1), so that, at maximum grip pressure, the device receptacle is not pressed onto the injection device and no friction or retaining forces can be transmitted in the longitudinal direction via the device receptacle between the injection device (1) and the add-on module (2) while bypassing the force sensor (22). - Injection system according to claim 1, characterized in that the device receptacle at least partially surrounds the injection device in the attached state, the handle surrounding the device receptacle and having an extension of at least half a hand width of a user in the direction of the longitudinal axis.
- Injection system according to claim 2, characterized in that the add-on module has a holding mechanism which secures the injection device in the direction of the longitudinal axis in the attached state.
- Injection system according to any of claims 1 to 3, characterized in that the evaluation electronics system is designed to identify a movement of a stop element (15a, 15b) of the injection device, in particular a stop movement of the stop element which signals the start or the end of a discharge.
- Injection system according to claim 4, characterized in that the evaluation electronics system is designed to generate a multivalent event pattern from a measured force impact signal and to compare the generated multivalent event pattern with a base pattern.
- Injection system according to any of claims 1 to 3, characterized in that the add-on module has a microphone (23e) for measuring an acoustic signal of the injection process, and in that the evaluation electronics system is designed to identify, on the basis of measurements of the microphone, a movement of a stop element of the injection device which signals the start or the end of a discharge.
- Injection system according to any of claims 1 to 3, characterized in that the add-on module has an acceleration sensor, the evaluation electronics system being designed to conjointly evaluate measurements from the acceleration sensor and from the force sensor for event identification.
- Injection system according to any of the preceding claims,
characterized in that the add-on module comprises a wireless communication unit (23h) for communicating with a mobile device, and/or a status display (23d) for displaying a state of the injection device. - Injection system according to any of the preceding claims, the needle protection sleeve spring accelerating a stop element at the end of the discharge, characterized in that the add-on module is designed to identify a stop of the accelerated stop element from a force impact detected by the force sensor.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH01485/16A CH713114A2 (en) | 2016-11-09 | 2016-11-09 | Electronic add-on module for injection devices. |
| PCT/CH2017/050006 WO2018085952A1 (en) | 2016-11-09 | 2017-10-18 | Electronic add-on module for injection appliances |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP3538183A1 EP3538183A1 (en) | 2019-09-18 |
| EP3538183B1 true EP3538183B1 (en) | 2024-03-13 |
Family
ID=60201269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP17791921.4A Active EP3538183B1 (en) | 2016-11-09 | 2017-10-18 | Electronic add-on module for injection appliances |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US11291771B2 (en) |
| EP (1) | EP3538183B1 (en) |
| CH (1) | CH713114A2 (en) |
| WO (1) | WO2018085952A1 (en) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USD866757S1 (en) * | 2016-03-11 | 2019-11-12 | Millennium Pharmaceuticals, Inc. | Autoinjector |
| EP3519021B1 (en) | 2016-10-03 | 2025-08-13 | Ypsomed AG | Electronic module for monitoring injection devices |
| EP3366335B1 (en) | 2017-02-22 | 2021-07-14 | SHL Medical AG | Recording unit for medicament delivery device |
| CN111032117B (en) | 2017-08-30 | 2022-03-25 | 诺和诺德股份有限公司 | Flow communication unit with preservative |
| JP7345452B2 (en) | 2017-08-30 | 2023-09-15 | ノボ・ノルデイスク・エー/エス | Multi-use drug delivery device for drugs with less preservatives |
| USD917694S1 (en) * | 2018-04-09 | 2021-04-27 | Ypsomed Ag | Injection device add-on |
| JP7301874B2 (en) | 2018-04-13 | 2023-07-03 | ノボ・ノルデイスク・エー/エス | Flow communication unit having unconnected and connected configurations |
| WO2020016313A1 (en) | 2018-07-20 | 2020-01-23 | Novo Nordisk A/S | Autoinjection device having dose logging |
| EP3626288A1 (en) * | 2018-09-19 | 2020-03-25 | Tecpharma Licensing AG | Electronic add-on module for injectors |
| GB201815551D0 (en) * | 2018-09-24 | 2018-11-07 | Norton Healthcare Ltd | Injection device |
| GB201815552D0 (en) | 2018-09-24 | 2018-11-07 | Norton Healthcare Ltd | Injection device |
| CA3219286A1 (en) | 2018-10-03 | 2020-04-09 | Eli Lilly And Company | Status sensing systems within an injection device assembly |
| EP3735997A1 (en) * | 2019-05-08 | 2020-11-11 | Ypsomed AG | Electronic add-on module for injectors |
| JP7629874B2 (en) * | 2019-06-13 | 2025-02-14 | サノフイ | Apparatus for detecting a dose of medication delivered from an injection device - Patent application |
| CN112237352B (en) * | 2020-09-15 | 2021-12-10 | 昊天行医学科技(北京)股份有限公司 | Flowable traditional Chinese medicine intelligent pharmacy system based on big data |
| US11755128B2 (en) * | 2020-09-25 | 2023-09-12 | Apple Inc. | Stylus with compressive force sensor |
| CH718080A2 (en) | 2020-11-23 | 2022-05-31 | Ypsomed Ag | Secure wireless connections for medical devices. |
| CN112604084B (en) * | 2020-12-07 | 2023-04-07 | 杭州慧钥医疗器械科技有限公司 | Audio data acquisition method, device, equipment and readable storage medium |
| CH717352A2 (en) * | 2021-06-30 | 2021-10-29 | Ypsomed Ag | Auto-injector with an electronic module. |
| CN114795194B (en) * | 2022-04-17 | 2025-04-11 | 深圳刷新生物传感科技有限公司 | An integrated implant component of an implantable biosensor |
| EP4309702A1 (en) | 2022-07-21 | 2024-01-24 | Ypsomed AG | Injection device with play compensation |
| CN115429978B (en) * | 2022-09-21 | 2023-06-30 | 苏州芙迈蕾医疗科技有限公司 | Intelligent electronic injector control boosting device |
| CN120550258B (en) * | 2025-07-30 | 2025-09-26 | 苏州嘉树医疗科技有限公司 | Disposable injection pen and injection unlocking structure thereof |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7078679B2 (en) | 2002-11-27 | 2006-07-18 | Wisconsin Alumni Research Foundation | Inductive detection for mass spectrometry |
| WO2006045525A1 (en) | 2004-10-21 | 2006-05-04 | Novo Nordisk A/S | Injection device with a processor for collecting ejection information |
| DE102006006784A1 (en) | 2006-02-14 | 2007-08-16 | Tecpharma Licensing Ag | Metering module for injection device, has sensor element, generating magnetic field and sensor actuation element caused change in position of magnetic field of sensor element |
| EP2065064A1 (en) | 2007-11-29 | 2009-06-03 | Valtronic Technologies (Suisse) SA | Pen injector for medication |
| EP2349412B1 (en) | 2008-10-01 | 2019-07-24 | Novo Nordisk A/S | Medical assembly with monitoring device |
| ES2713177T3 (en) | 2008-10-28 | 2019-05-20 | Hoffmann La Roche | A procedure for monitoring the operation of a medication delivery device, an electronic module and a medication delivery system |
| JP5562969B2 (en) | 2008-11-06 | 2014-07-30 | ノボ・ノルデイスク・エー/エス | Electronically assisted drug delivery device |
| US9724475B2 (en) * | 2009-02-27 | 2017-08-08 | Lifescan, Inc. | Drug delivery management systems and methods |
| JP6116570B2 (en) * | 2011-09-08 | 2017-04-19 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | Method and monitoring device for monitoring the operation of a drug delivery device |
| WO2013120774A1 (en) * | 2012-02-13 | 2013-08-22 | Sanofi-Aventis Deutschland Gmbh | Pen-type injection device and electronic clip-on module therefor |
| EP3453416B1 (en) * | 2012-02-13 | 2020-12-02 | Sanofi-Aventis Deutschland GmbH | A supplementary device for a manually operable injection device |
| JP6590693B2 (en) | 2012-08-10 | 2019-10-16 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | Pen-type drug injection device and electronic extension monitoring module for monitoring and logging dose setting and administration |
| US20150290396A1 (en) * | 2012-10-23 | 2015-10-15 | Insuline Medical Ltd. | Drug dispensing-tracking device, system and method |
| US9692829B2 (en) * | 2012-12-03 | 2017-06-27 | Mylan Inc. | Medication delivery system and method |
| EP3590568A1 (en) | 2013-03-22 | 2020-01-08 | TecPharma Licensing AG | Substance dispensing device with a signalling device |
| WO2016049066A1 (en) * | 2014-09-23 | 2016-03-31 | Oscillari Llc | Vibration sensor based drug delivery monitor |
| WO2015136564A1 (en) * | 2014-03-10 | 2015-09-17 | Osvaldo Tufi | Add-on module for monitoring and control of compliance to therapy for injectable drugs contained in pre-filled syringes |
| ES2935770T3 (en) | 2014-05-06 | 2023-03-09 | Univ North Carolina Chapel Hill | Devices, systems and procedures for volumetrically measuring fluid in a syringe |
| WO2016102407A1 (en) | 2014-12-22 | 2016-06-30 | Sanofi-Aventis Deutschland Gmbh | Drug delivery device with electromagnetic drive unit |
| CN107405448B (en) * | 2015-01-23 | 2021-03-23 | 伯克顿迪金森公司 | Method and apparatus for acquiring dose dialing events |
| EP3135330A1 (en) * | 2015-08-24 | 2017-03-01 | Carebay Europe Ltd. | Monitoring unit |
| CH711618A2 (en) | 2015-10-07 | 2017-04-13 | Tecpharma Licensing Ag | Administration device with activatable identification means. |
| EP3162396A1 (en) * | 2015-10-28 | 2017-05-03 | Carebay Europe Ltd. | Medicament delivery device |
| EP3519021B1 (en) | 2016-10-03 | 2025-08-13 | Ypsomed AG | Electronic module for monitoring injection devices |
-
2016
- 2016-11-09 CH CH01485/16A patent/CH713114A2/en not_active Application Discontinuation
-
2017
- 2017-10-18 EP EP17791921.4A patent/EP3538183B1/en active Active
- 2017-10-18 WO PCT/CH2017/050006 patent/WO2018085952A1/en not_active Ceased
-
2019
- 2019-05-03 US US16/402,824 patent/US11291771B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CH713114A2 (en) | 2018-05-15 |
| EP3538183A1 (en) | 2019-09-18 |
| US11291771B2 (en) | 2022-04-05 |
| US20190255252A1 (en) | 2019-08-22 |
| WO2018085952A1 (en) | 2018-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3538183B1 (en) | Electronic add-on module for injection appliances | |
| EP3930793B1 (en) | Autoinjector with discharge detection | |
| US12337152B2 (en) | Click event identification in delivery devices | |
| EP3359229B1 (en) | Injector with destroyable electric circuit due to usage | |
| EP1772099B1 (en) | Piercing system | |
| EP3659653B1 (en) | Autoinjector with selectable triggering mode | |
| US12440624B2 (en) | Electronic add-on module for injection devices | |
| DE10332283A1 (en) | System for taking body fluid | |
| EP1891898A1 (en) | Lancing device | |
| WO2018178888A1 (en) | Monitoring an injection process | |
| CH717369A2 (en) | Additional electronic module for injection devices. | |
| EP4373548A1 (en) | Autoinjector with a separable electronics module | |
| WO2023275273A1 (en) | Autoinjector with an electronics module | |
| EP2258423A1 (en) | Reusable syringe with replaceable tubular vial and retractable needle | |
| EP4387702A1 (en) | Microneedle device and method for detecting at least one force acting on a microneedle array | |
| WO2021219371A1 (en) | Electronic add-on module for injection devices | |
| EP4194033A1 (en) | Delivery device for delivering an active agent from a multi-compartment container | |
| WO2020225269A1 (en) | Injection system having electronic add-on module | |
| WO2023051963A1 (en) | Administering devices which can communicate via visible light | |
| DE102013013685A1 (en) | Method and device system for blood glucose determination and optionally optimized insulin application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20190611 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: YPSOMED AG |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| 17Q | First examination report despatched |
Effective date: 20211111 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
| INTG | Intention to grant announced |
Effective date: 20231013 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 502017015927 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 |
|
| REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240614 |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20240313 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240613 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240613 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240613 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240614 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240713 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240715 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240715 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240713 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 502017015927 Country of ref document: DE |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20241022 Year of fee payment: 8 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20241024 Year of fee payment: 8 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20241025 Year of fee payment: 8 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20241101 Year of fee payment: 8 |
|
| 26N | No opposition filed |
Effective date: 20241216 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240313 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20241031 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20241018 |
|
| REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20241031 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20241018 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: U11 Free format text: ST27 STATUS EVENT CODE: U-0-0-U10-U11 (AS PROVIDED BY THE NATIONAL OFFICE) Effective date: 20251101 |